America,” the latest short film from award-winning Brazilian director Aly Muritiba, has released its first trailer. The ...

During remarks about pharmaceutical investments, President Donald Trump downplayed the billions pledged by Novo Nordisk and ...

A helpful guide on which new releases to watch, including movies in theaters, on streaming or available to rent or buy on ...

Dr. Mehmet Oz claimed that Americans could lose billions of pounds by next year.

It appears problems at Novo Nordisk’s recently acquired manufacturing facility in Indiana aren’t going to be solved any time soon. The FDA has tagged the former Catalent facility with an official ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

After Omeros decided to hit pause on developing its MASP-3 inhibitor zaltenibart, Novo Nordisk has spied an opportunity to scoop up the rare disease drug. Omeros spent the first weeks of the year ...

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

Novo Nordisk A/S agreed to buy Akero Therapeutics Inc. for as much as $5.2 billion to expand its portfolio in a type of liver disease that’s linked to obesity. Novo will pay $54 a share in cash, ...

Novo Nordisk is acquiring Akero Therapeutics for up to $5.2bn, aiming to diversify beyond semaglutide and strengthen its position in MASH and cirrhosis. The deal brings Akero's EFX, a promising FGF21 ...